4.6 Article

ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis

Journal

CANCER IMMUNOLOGY RESEARCH
Volume 6, Issue 2, Pages 151-162

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2326-6066.CIR-17-0114

Keywords

-

Funding

  1. NIH [R01-AI44129, CA108835, U01 AI113315]
  2. Bristol Myers-Squibb
  3. Pershing Square Sohn Cancer Research Foundation
  4. PaineWebber Chair
  5. Stand Up To Cancer
  6. STARR Cancer Consortium
  7. MSK Core Grant [P30 CA008748]
  8. Stand Up To Cancer - American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]
  9. American Association for Cancer Research, the scientific partner of SU2C

Ask authors/readers for more resources

Despite a dramatic increase in T-cell receptor (TCR) sequencing, few approaches biologically parse the data in a fashion that both helps yield new information about immune responses and may guide immunotherapeutic interventions. To address this issue, we developed a method, ImmunoMap, that utilizes a sequence analysis approach inspired by phylogenetics to examine TCR repertoire relatedness. ImmunoMap analysis of the CD8 T-cell response to self-antigen (K-b-TRP2) or to a model foreign antigen (K-b-SIY) in naive and tumor-bearing B6 mice showed differences in the T-cell repertoire of self-versus foreign antigen-specific responses, potentially reflecting immune pressure by the tumor, and also detected lymphoid organ-specific differences in TCR repertoires. When ImmunoMap was used to analyze clinical trial data of tumor-infiltrating lymphocytes from patients being treated with anti-PD-1, ImmunoMap, but not standard TCR sequence analyses, revealed a clinically predicative signature in pre- and posttherapy samples. (C) 2017 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available